Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZATHIOPRINE Cause Pulmonary function test decreased? 13 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Pulmonary function test decreased have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.0% of all adverse event reports for AZATHIOPRINE.

13
Reports of Pulmonary function test decreased with AZATHIOPRINE
0.0%
of all AZATHIOPRINE reports
3
Deaths
0
Hospitalizations

How Dangerous Is Pulmonary function test decreased From AZATHIOPRINE?

Of the 13 reports, 3 (23.1%) resulted in death.

Is Pulmonary function test decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does AZATHIOPRINE Cause?

Drug ineffective (8,076) Off label use (5,358) Drug intolerance (3,392) Condition aggravated (2,832) Rheumatoid arthritis (2,746) Treatment failure (2,483) Arthralgia (2,427) Drug hypersensitivity (2,421) Nausea (2,178) Pneumonia (2,157)

What Other Drugs Cause Pulmonary function test decreased?

IVACAFTOR\LUMACAFTOR (378) ALBUTEROL (325) BUDESONIDE\FORMOTEROL (304) OMALIZUMAB (288) PREDNISONE (275) AZTREONAM LYSINE (252) TIOTROPIUM (223) PIRFENIDONE (207) ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (192) TOBRAMYCIN (190)

Which AZATHIOPRINE Alternatives Have Lower Pulmonary function test decreased Risk?

AZATHIOPRINE vs AZD-1222 AZATHIOPRINE vs AZELAIC ACID AZATHIOPRINE vs AZELASTINE AZATHIOPRINE vs AZELASTINE\FLUTICASONE AZATHIOPRINE vs AZELNIDIPINE

Related Pages

AZATHIOPRINE Full Profile All Pulmonary function test decreased Reports All Drugs Causing Pulmonary function test decreased AZATHIOPRINE Demographics